(Reuters) – The United States has administered more than 7,300 doses of Novavax Inc’s COVID-19 shot, which health officials hope will convince more people to opt for vaccinations as it …
novavax
-
-
(Reuters) – Vaccine maker Novavax on Tuesday said that the U.S. Food and Drug Administration had cleared a lot of its COVID vaccine for release in the United States, and …
-
NEW ORLEANS, July 1, 2022 — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces …
-
(Reuters) – Shares of Novavax Inc surged nearly 20% on Wednesday after advisers to the Food and Drug Administration overwhelmingly backed the use of its COVID-19 vaccine, bringing the shot …
-
(Reuters) – Novavax Inc’s shares plunged nearly 20% in premarket trading on Tuesday due to uncertainty over global demand for the company’s COVID-19 vaccine following a slow start to deliveries. …
-
(Reuters) – Novavax Inc said on Wednesday it had filed an application with Britain’s drugs regulator for the authorization of its COVID-19 vaccine among adolescents aged 12 and older. Britain …
-
– Novavax Inc said on Monday it had received interim authorization from the Singapore Health Sciences Authority (HSA) for its COVID-19 vaccine in adults. (Reporting by Dania Nadeem in Bengaluru)
-
– Novavax Inc has submitted an application to Switzerland’s drugs regulator for the authorization of its COVID-19 vaccine in adults, the U.S. vaccine maker said on Monday. The submission is …
-
By Riham Alkousaa BERLIN – Benedikt Richter, a 40-year-old teacher in the southwest German city of Kaiserslautern, long held out against getting vaccinated against COVID-19. He felt uneasy about the …
-
SEOUL -South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge of COVID-19 omicron infections, authorising the use of Novavax Inc’s vaccine on Wednesday and …
-
– Novavax said on Tuesday the World Health Organization’s (WHO) panel of experts had recommended a third dose of its vaccine, NVX-CoV2373, for immunocompromised persons. The WHO’s Strategic Advisory Group …
-
– The European Union’s drug regulator said on Wednesday it could decide on Novavax’s COVID-19 vaccine approval “within weeks” if the data it has received from the drugmaker was sufficient …
-
By Mrinalika Roy and Carl O’Donnell -Vaccine developer Novavax Inc said on Thursday it has completed the submission process for emergency use listing of its COVID-19 vaccine candidate with the …